|
2022 Other Outputs My Health for Life Performance Measurement Report 1, July - December 2021Maravilla, Joemer, Rossa, Kalina, Young, Charlotte, Burger, Sarah-Ann, Nuttal, Gina and Robinson, Mark (2022). My Health for Life Performance Measurement Report 1, July - December 2021. Brisbane, Australia: Institute for Social Science Research, The University of Queensland. |
|
2022 Journal Article Trends of perinatal mental health referrals and psychiatric admissions in QueenslandSan Martin Porter, Macarena A, Maravilla, Joemer, Kisely, Steve, Betts, Kim S, Salom, Caroline and Alati, Rosa (2022). Trends of perinatal mental health referrals and psychiatric admissions in Queensland. Australian and New Zealand Journal of Psychiatry, 57 (3) 00048674221080405, 000486742210804-410. doi: 10.1177/00048674221080405 |
|
2022 Other Outputs Evaluation of the Pharmaceutical Benefits Scheme subsidised take home naloxone pilot - Final ReportSalom, Caroline L., Maravilla, Joemer C., Thomas, Natalie, Juckel, Jennifer, Daly, Catherine, Peacock, Amy and Gisev, Natasa (2022). Evaluation of the Pharmaceutical Benefits Scheme subsidised take home naloxone pilot - Final Report. Canberra, ACT Australia: Australian Department of Health. doi: 10.13140/RG.2.2.18935.91046 |
|
2022 Other Outputs Queensland Drug Trends 2021: key findings from the Ecstasy And Related Drugs Reporting System (EDRS) interviewsJuckel, Jennifer, Thomas, Natalie, Daly, Catherine, Maravilla, Joemer and Salom, Caroline (2022). Queensland Drug Trends 2021: key findings from the Ecstasy And Related Drugs Reporting System (EDRS) interviews. Australian Drug Trends Series Sydney, NSW, Australia: National Drug and Alcohol Research Centre. doi: 10.26190/8q7z-3620 |
|
2022 Other Outputs Queensland Drug Trends 2021: key findings from the illicit drug reporting system (IDRS) interviewsJuckel, Jennifer, Thomas, Natalie, Maravilla, Joemer, Daly, Catherine and Salom, Caroline (2022). Queensland Drug Trends 2021: key findings from the illicit drug reporting system (IDRS) interviews. Illicit Drugs Reporting System Sydney, NSW, Australia: National Drug and Alcohol Research Centre. doi: 10.26190/ftn4-sd95 |
|
2022 Other Outputs Microdosing amongst people who regularly use ecstasy and other illicit stimulants in Queensland and Tasmania, Australia, 2021Thomas, Natalie, Northcote, Mitchell, Juckel, Jennifer, Daly, Catherine, Maravilla, Joemer, Wilson, Yalei, Bruno, Raimondo and Salom, Caroline (2022). Microdosing amongst people who regularly use ecstasy and other illicit stimulants in Queensland and Tasmania, Australia, 2021. Sydney, NSW, Australia: National Drug and Alcohol Research Centre, UNSW Sydney. doi: 10.26190/374n-wn67 |
|
2021 Journal Article Opioid medication prescribing in Queensland, 1997‒2018: a population studyAdewumi, Adeleke D., Maravilla, Joemer C., Alati, Rosa, Hollingworth, Samantha A., Hu, Xuelei, Loveday, Bill and Connor, Jason (2021). Opioid medication prescribing in Queensland, 1997‒2018: a population study. Medical Journal of Australia, 215 (3) mja2.51115, 137-138. doi: 10.5694/mja2.51115 |
|
2021 Journal Article The risk of anxiety disorders in children of parents with severe psychiatric disorders: a systematic review and meta-analysisAyano, Getinet, Betts, Kim, Maravilla, Joemer Calderon and Alati, Rosa (2021). The risk of anxiety disorders in children of parents with severe psychiatric disorders: a systematic review and meta-analysis. Journal of Affective Disorders, 282, 472-487. doi: 10.1016/j.jad.2020.12.134 |
|
2021 Other Outputs Trends in self-reported past year non-fatal overdose and responses to overdose: findings from the Illicit Drug Reporting SystemThomas, Natalie, Juckel, Jennifer, Daly, Catherine, Maravilla, Joemer and Salom, Caroline (2021). Trends in self-reported past year non-fatal overdose and responses to overdose: findings from the Illicit Drug Reporting System. Sydney, Australia: National Drug and Alcohol Research Centre, UNSW Sydney. |
|
2021 Other Outputs DFV Specialist Health Workforce Program Evaluation PlanBoyle, F. M., Maravilla, J. C., Dean, J., Lohan, A., Thomas, N. and Salom, C. (2021). DFV Specialist Health Workforce Program Evaluation Plan. Brisbane, QLD Australia: Institute for Social Science Research, The University of Queensland. |
|
2021 Other Outputs DFV Specialist Health Workforce Program Evaluation — Literature ReviewThomas, N., Dean, J., Lohan, A., Maravilla, J. C., Salom, C. L. and Boyle, F. M. (2021). DFV Specialist Health Workforce Program Evaluation — Literature Review. Brisbane, QLD Australia: Institute for Social Science Research, The University of Queensland. |
|
2020 Journal Article Stunting of children under two from repeated pregnancy among young mothersMaravilla, Joemer Calderon, Betts, Kim, Adair, Linda and Alati, Rosa (2020). Stunting of children under two from repeated pregnancy among young mothers. Scientific Reports, 10 (1) 14265, 14265. doi: 10.1038/s41598-020-71106-7 |
|
2020 Other Outputs Evaluation of the Pharmaceutical Benefits Scheme Subsidised Take Home Naloxone Pilot: Interim Report 2Salom, Caroline, Maravilla, Joemer, Thomas, Natalie, Juckel, Jennifer, Daly, Catherine, Gisev, Natasa, Peacock, Amy and McDaid, Lisa (2020). Evaluation of the Pharmaceutical Benefits Scheme Subsidised Take Home Naloxone Pilot: Interim Report 2. Brisbane, QLD, Australia: Institute for Social Science Research, The University of Queensland. |
|
2020 Journal Article Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019Vos, Theo, Lim, Stephen S, Abbafati, Cristiana, Abbas, Kaja M, Abbasi, Mohammad, Abbasifard, Mitra, Abbasi-Kangevari, Mohsen, Abbastabar, Hedayat, Abd-Allah, Foad, Abdelalim, Ahmed, Abdollahi, Mohammad, Abdollahpour, Ibrahim, Abolhassani, Hassan, Aboyans, Victor, Abrams, Elissa M, Abreu, Lucas Guimarães, Abrigo, Michael R M, Abu-Raddad, Laith Jamal, Abushouk, Abdelrahman I, Acebedo, Alyssa, Ackerman, Ilana N, Adabi, Maryam, Adamu, Abdu A, Adebayo, Oladimeji M, Adekanmbi, Victor, Adelson, Jaimie D, Adetokunboh, Olatunji O, Adham, Davoud, Afshari, Mahdi ... Murray, Christopher J L (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 396 (10258), 1204-1222. doi: 10.1016/S0140-6736(20)30925-9 |
|
2020 Journal Article Five insights from the Global Burden of Disease Study 2019Abbafati, Cristiana, Abbas, Kaja M., Abbasi, Mohammad, Abbasifard, Mitra, Abbasi-Kangevari, Mohsen, Abbastabar, Hedayat, Abd-Allah, Foad, Abdelalim, Ahmed, Abdollahi, Mohammad, Abdollahpour, Ibrahim, Abedi, Aidin, Abedi, Parisa, Abegaz, Kedir Hussein, Abolhassani, Hassan, Abosetugn, Akine Eshete, Aboyans, Victor, Abrams, Elissa M., Abreu, Lucas Guimaraes, Abrigo, Michael R. M., Abu Haimed, Abdulaziz Khalid, Abualhasan, Ahmed, Abu-Gharbieh, Eman, Abu-Raddad, Laith Jamal, Abushouk, Abdelrahman I., Acebedo, Alyssa, Ackerman, Ilana N., Adabi, Maryam, Adair, Tim, Adamu, Abdu A. ... Murray, Christopher J. L. (2020). Five insights from the Global Burden of Disease Study 2019. Lancet, 396 (10258), 1135-1159. |
|
2020 Journal Article Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019Murray, Christopher J L, Aravkin, Aleksandr Y, Zheng, Peng, Abbafati, Cristiana, Abbas, Kaja M, Abbasi-Kangevari, Mohsen, Abd-Allah, Foad, Abdelalim, Ahmed, Abdollahi, Mohammad, Abdollahpour, Ibrahim, Abegaz, Kedir Hussein, Abolhassani, Hassan, Aboyans, Victor, Abreu, Lucas Guimarães, Abrigo, Michael R M, Abualhasan, Ahmed, Abu-Raddad, Laith Jamal, Abushouk, Abdelrahman I, Adabi, Maryam, Adekanmbi, Victor, Adeoye, Abiodun Moshood, Adetokunboh, Olatunji O, Adham, Davoud, Advani, Shailesh M, Agarwal, Gina, Aghamir, Seyed Mohammad Kazem, Agrawal, Anurag, Ahmad, Tauseef, Ahmadi, Keivan ... Lim, Stephen S (2020). Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 396 (10258), 1223-1249. doi: 10.1016/S0140-6736(20)30752-2 |
|
2020 Journal Article Pharmaceutical opioids utilisation by dose, formulation, and socioeconomic status in Queensland, Australia: a population study over 22 yearsAdewumi, Adeleke D., Maravilla, Joemer C., Alati, Rosa, Hollingworth, Samantha A., Hu, Xuelei, Loveday, Bill and Connor, Jason P. (2020). Pharmaceutical opioids utilisation by dose, formulation, and socioeconomic status in Queensland, Australia: a population study over 22 years. International Journal of Clinical Pharmacy, 43 (2), 328-339. doi: 10.1007/s11096-020-01155-5 |
|
2020 Journal Article Multiple opioid prescribers: a genuine quest for treatment rather than aberrant behaviour. A two-decade population-based studyAdewumi, Adeleke D., Maravilla, Joemer C., Alati, Rosa, Hollingworth, Samantha A., Hu, Xuelei, Loveday, Bill and Connor, Jason P. (2020). Multiple opioid prescribers: a genuine quest for treatment rather than aberrant behaviour. A two-decade population-based study. Addictive Behaviors, 108 106458, 1-8. doi: 10.1016/j.addbeh.2020.106458 |
|
2020 Journal Article Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000-17Local Burden of Disease Diarrhoea Collaborators, Endalamaw, Aklilu, Mamun, Abdullah A., Maravilla, Joemer, Hasan, Md. Mehedi, Shifti, Desalegn Markos, Shiferaw, Wondimeneh and Sartorius, Benn (2020). Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000-17. The Lancet Global health, 8 (8), e1038-e1060. doi: 10.1016/S2214-109X(20)30230-8 |
|
2020 Journal Article Duration of opioid use and association with socioeconomic status, daily dose and formulation: a two-decade population study in Queensland, AustraliaAdewumi, Adeleke D., Maravilla, Joemer C., Alati, Rosa, Hollingworth, Samantha A., Hu, Xuelei, Loveday, Bill and Connor, Jason P. (2020). Duration of opioid use and association with socioeconomic status, daily dose and formulation: a two-decade population study in Queensland, Australia. International Journal of Clinical Pharmacy, 43 (2), 340-350. doi: 10.1007/s11096-020-01079-0 |
